Facebook Linkedin Twitter
Inside Precision Medicine Lipoprotein(a) Lowering Draw Between Lilly and Silence

Phase II clinical trials (Drug development)

Illustration of red blood cells moving through clogged artery to indicate cholesterol build up as a result of familial hypercholesterolemia and atherosclerosis, which can be caused by high levels of lipoprotein(a) or Lp(a).
News & Features

Lipoprotein(a) Lowering Draw Between Lilly and Silence

0
Malignant peripheral nerve sheath tumors (MPNST)
News & Features

In “Quantum Leap,” Almost Half of Adults and Children with NF1 Respond to MEK Inhibitor

0
Melanoma cancer cells of human under microscope
News & Features

New Drug Combo Shows Significant Promise in Advanced Melanoma Trial 

0
3d illustration of the human brain with visible blood vessels illustrating Alzheimer's disease and dementia.
News & Features

AviadoBio and Astellas Ink Potential $2.5B+ Deal for Frontotemporal Dementia Candidate 

0
3D image illustrating immune cells attacking cancer cells in immunotherapy such as that used in cancers with mismatch repair deficiency
News & Features

BioNTech’s mRNA Vaccine Combo Scores in Phase II

0
Image showing heart failure
News & Features

Cardurion Raises $260M to Advance Novel CV Drugs

0
Capsule with DNA inside
News & Features

Promising Early Results from Lexeo’s Gene Therapy for Friedreich Ataxia Cardiomyopathy

0
Colorectal Cancer
News & Features

New Cellular Immunotherapy Shows Promise against Solid Tumors in Phase II Trial

0
Lung Cancer
News & Features

IDEAYA’s MAT2A Inhibitor Scores in Phase II for Urothelial and NSCLC

0
3D Rendering of Antibody Drug Conjugate Molecules
News & Features

Eisai and BMS End ADC Deal, But Eisai Will Continue Development

0
123...6Page 1 of 6

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine